Skip to main content
. 2018 Mar 26;17:1176935118766522. doi: 10.1177/1176935118766522

Table 2.

Significant differentially expressed genes in the MAPK-signaling pathway where fold change is <0.67 or >1.50.

Gene name Tumor mean Normal mean Fold change P value Adjusted P value
Downregulated
 FGF9 1.66 9.08 0.18 4.27E−30 6.44E−29
 PPP3R2 0.20 0.93 0.21 3.56E−07 8.02E−07
 CACNG3 0.16 0.62 0.25 4.46E−04 7.32E−04
 CACNG7 0.17 0.67 0.25 1.91E−05 3.48E−05
 CACNA1A 3.27 12.58 0.26 2.27E−32 4.57E−31
 CACNA1G 1.26 4.80 0.26 4.08E−16 1.79E−15
 CACNA1F 1.68 6.25 0.27 1.60E−21 1.01E−20
 RASGRP2 6.72 24.73 0.27 1.04E−31 1.93E−30
 PRKCB 14.65 53.12 0.28 1.52E−41 7.31E−40
 CACNA1I 1.91 6.56 0.29 8.80E−19 4.51E−18
 MAPK10 9.26 28.10 0.33 8.93E−34 1.96E−32
 MAP4K1 7.24 21.46 0.34 1.58E−26 1.74E−25
 CACNG2 0.21 0.57 0.37 2.28E−03 3.41E−03
 PRKACB 62.60 162.73 0.38 5.72E−40 1.97E−38
 FGFR2 26.51 68.82 0.39 2.32E−21 1.40E−20
 MEF2C 27.15 66.82 0.41 1.00E−41 6.02E−40
 FOS 185.52 453.52 0.41 9.65E−31 1.66E−29
 CACNG1 0.27 0.65 0.42 3.35E−05 5.89E−05
 FGF10 1.70 4.06 0.42 1.85E−10 5.45E−10
 PTPN5 0.89 2.09 0.42 7.08E−07 1.55E−06
 DUSP1 67.66 154.53 0.44 1.02E−34 2.46E−33
 EGF 2.83 6.34 0.45 1.71E−05 3.15E−05
 CACNB2 26.71 59.55 0.45 1.00E−38 3.03E−37
 IL1R2 7.02 15.61 0.45 1.00E−13 3.77E−13
 NTRK1 1.10 2.43 0.45 3.24E−07 7.36E−07
 CACNA1B 1.79 3.91 0.46 1.99E−06 4.14E−06
 NTRK2 17.81 38.41 0.46 1.04E−08 2.67E−08
 DUSP5 28.27 59.40 0.48 1.39E−22 9.28E−22
 CACNA1H 53.11 106.08 0.50 5.22E−27 5.99E−26
 FGFR3 36.15 70.78 0.51 1.13E−18 5.54E−18
 MAPT 4.51 8.74 0.52 1.01E−12 3.40E−12
 NFATC1 12.01 22.97 0.52 3.23E−17 1.50E−16
 PDGFRA 88.47 166.61 0.53 5.08E−26 5.11E−25
 CACNA2D3 1.56 2.91 0.53 1.46E−04 2.46E−04
 MAPK7 21.28 38.75 0.55 6.78E−29 9.08E−28
 FAS 28.16 50.95 0.55 2.75E−24 2.46E−23
 CACNA1S 0.56 1.00 0.56 6.90E−03 1.00E−02
 RASGRP1 21.77 38.90 0.56 1.20E−22 8.23E−22
 PRKACG 0.17 0.31 0.56 1.84E−03 2.79E−03
 RASGRP3 25.53 45.22 0.56 1.16E−20 6.81E−20
 FGF2 10.04 17.66 0.57 2.79E−13 9.89E−13
 FGF13 2.42 4.18 0.58 2.84E−05 5.06E−05
 vRAC2 22.11 37.39 0.59 4.70E−16 2.02E−15
 FGF7 8.17 13.70 0.60 1.49E−08 3.69E−08
 NTF3 0.84 1.41 0.60 1.04E−03 1.61E−03
 RPS6KA1 89.25 148.07 0.60 1.24E−30 2.00E−29
 JUND 127.78 210.71 0.61 1.88E−36 5.04E−35
 PLA2G4F 22.98 37.48 0.61 2.67E−10 7.76E−10
 CACNA2D2 10.30 16.63 0.62 1.02E−08 2.63E−08
 RPS6KA5 18.57 29.87 0.62 1.84E−15 7.76E−15
 FLNC 46.98 75.44 0.62 3.90E−09 1.02E−08
 ARRB1 52.99 84.74 0.63 4.44E−24 3.61E−23
 NR4A1 201.17 319.66 0.63 5.51E−11 1.72E−10
 FASLG 1.07 1.70 0.63 4.96E−03 7.29E−03
 IL1R1 57.71 89.40 0.65 9.55E−17 4.34E−16
 HSPA2 7.29 11.21 0.65 5.51E−06 1.08E−05
 PTPN7 16.22 24.78 0.65 3.08E−08 7.57E−08
 MAP3K14 33.86 51.73 0.65 1.46E−24 1.35E−23
 MAP2K6 25.29 38.55 0.66 1.60E−10 4.77E−10
 MKNK1 63.58 95.95 0.66 2.04E−27 2.46E−26
Upregulated
 HSPB1 60.24 40.01 1.51 3.87E−12 1.24E−11
 TGFBR1 106.44 70.13 1.52 6.14E−19 3.21E−18
 STK3 41.26 26.65 1.55 1.64E−18 7.88E−18
 HSPA6 5.49 3.43 1.60 3.67E−05 6.40E−05
 ELK1 49.96 30.79 1.62 4.90E−24 3.81E−23
 DUSP10 27.04 16.22 1.67 3.95E−14 1.59E−13
 FGF1 4.77 2.79 1.71 9.30E−06 1.75E−05
 TP53 105.07 59.63 1.76 3.25E−24 2.79E−23
 HSPA1B 102.12 55.34 1.85 4.49E−24 3.61E−23
 PDGFRB 166.24 87.76 1.89 8.03E−28 1.02E−26
 TGFB2 9.23 4.52 2.04 8.04E−14 3.13E−13
 FGF18 1.90 0.85 2.22 1.27E−05 2.36E−05
 HSPA8 631.28 273.40 2.31 5.34E−56 1.29E−53
 CACNG8 7.57 3.27 2.32 7.89E−10 2.19E−09
 STMN1 77.81 31.07 2.50 1.15E−40 4.63E−39
 DUSP4 56.69 21.44 2.64 2.53E−22 1.65E−21
 CDC25B 169.88 60.96 2.79 9.71E−54 7.80E−52
 IL1A 7.56 2.39 3.17 2.02E−19 1.08E−18
 NTF4 0.55 0.17 3.23 3.80E−06 7.57E−06
 CACNG4 3.41 1.03 3.30 8.11E−10 2.22E−09
 MYC 181.11 49.00 3.70 5.76E−55 6.94E−53
 FGF20 0.72 0.14 5.29 2.29E−05 4.15E−05
 FGF19 1.39 0.15 9.42 6.08E−13 2.12E−12